AzTrials
AzTrials

Child MalnutritionFAQR-BurkinaNCT02071563

Effectiveness and Cost-Effectiveness of Four Formulations of Food Supplements for the Prevention of Wasting and Stunting in Burkina Faso

A study testing CSB14, RUSF1 and SC+ in people with Child Malnutrition, run by Tufts University at 1 site in Burkina Faso.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This research will serve as a follow-up on the review of Title II commodities performed by the Food Aid Quality Review at Tufts University in October 2011. The study in Burkina Faso will test the relative effectiveness and cost effectiveness of four supplementary foods in the prevention of MAM and stunting in normal… Read more about this study

Who is it for?
Ages 6 to 23 monthsHealthy volunteers can take part
Conditions the study is for
Child Malnutrition
What is being tested?
CSB14, RUSF1 and SC+
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6,039 participants
Where
1 siteBurkina Faso
Study dates
Mar 2014to Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 23 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Child enrolled in the ViM program to receive ration from a Food Distribution Point
  • Beneficiary Mother/Caretaker whose child turns 6 months old and is enrolled in ViM program to receive ration during the study period
  • Beneficiary Mother/Caretaker has no age restrictions for inclusion (Note: Mothers/caretakers will be asked to participate regardless of age and consented appropriately; it is possible some mothers may be minors)
  • Subject who is voluntarily willing to participate and indicates by signing (or marking with a thumbprint) the consent form.
  • Exclusion Criteria • Beneficiary Mothers/Caretakers who participate in an interview, observation or FGD once for this study will not be eligible again for participation
  • Health and Nutrition Promoters (HNP) Inclusion Criteria
Show all 26Show fewer
  • HNP who covers the catchment area of the FDPs
  • Subject who is voluntarily willing to participate by signing the consent form
  • Community Health Agents (CHA) Inclusion Criteria
  • Community Health Agents serving within the catchment area for the FDPs
  • Community Health Agents that have been present during the study period
  • Subject who is voluntarily willing to participate and indicates by signing the consent form
  • PVO Staff Members Inclusion Criteria
  • All staff members from ACDI/VOCA and Save the Children who are directly involved in the ViM program
  • Subject who is voluntarily willing to participate and indicates by signing the consent form Exclusion Criteria
  • PVO Staff members who joined too recently to have experience of the program change (new commodities)
  • Village Elders/Headmen Inclusion Criteria
  • Village elder/headmen in study commune
  • Subject who is voluntarily willing to participate and indicates by signing the consent form Exclusion Criteria
  • Village elder/headmen whose community is not involved in the feeding program
  • Store Owners/Market Vendor Inclusion Criteria
  • Store owner/market vendor in study communes who trades in the relevant products (food vendors)
  • Subject who is voluntarily willing to participate and indicates by signing the consent form Exclusion Criteria
  • Vendors who do not sell food.
  • The withdrawal/termination criterion for this study is not applicable as the subject's participation will not be terminated by the investigator, and there are no necessary precautions applied to those who withdraw.
  • Study subjects may not participate in another research study that provides supplementary food as a food ration to children between 6-23 months.

Who cannot join

  • Children who are over 6 months of age when the study begins
  • Children receiving food rations from another organization (e.g. World Food Programme or UNICEF)
  • Beneficiary Mothers/Caretakers (Mothers/Caretakers of Children 6 -23 months old)

Trial locations and contacts

1 site in 1 country.

Burkina Faso1 site
  • Study site

    Kaya, Sanmatenga

Other trials in Burkina Faso

About this study

Official title: Food Aid Quality Review Phase II Effectiveness Study: Preventing MAM and Stunting in Burkina Faso

This research will serve as a follow-up on the review of Title II commodities performed by the Food Aid Quality Review at Tufts University in October 2011. The study in Burkina Faso will test the relative effectiveness and cost effectiveness of four supplementary foods in the prevention of MAM and stunting in normal programmatic settings.

The aims of this study are to:

  1. To compare the effectiveness of four alternative supplementary food commodities in preventing stunting and wasting, and promoting linear growth in children 6 - 23 months in the context of a preventive supplementary feeding program in Burkina Faso.
  2. To estimate the relative cost of implementing the supplementary feeding program using each commodity
  3. To estimate the relative cost/effectiveness of implementing the program using each commodity.
Read the detailed description

Phase II of FAQR in Burkina Faso will assess the recommended improvements in the four arms of the study: CSB14 prepared with FVO, RUSF1, CSB+, and SC+.

The study will be a cluster-randomized, effectiveness trial. The study will use a mixed method technique of quantitative and qualitative data collection. The design of the study is quasi-experimental: food distribution sites (FDPs) (and the communities they serve) will be grouped into four clusters that are geographically contiguous with each other and sufficiently distant from each other so that the Beneficiaries are unlikely to have contact with each other. The four groups of food distribution points will be randomly assigned to one of four arms, defined by the specific food to be provided:

  1. Corn Soy Blend 14 (CSB14) (with whey protein concentrate and enhanced micronutrient profile), prepared with fortified vegetable oil (FVO); 75g CSB14/day, 22.5g FVO/day
  2. Ready-to use supplementary food 1 (RUSF1); 100g RUSF/day
  3. Super Cereal Plus (SC+)( has an enhanced nutrient profile, non-fat dry milk, and oil already embedded into the CSB); 122g SC+/day
  4. Corn Soy Blend Plus (CSB+) prepared with FVO; 75g CSB+/day, 22.5g FVO/day The CSB+ arm will act as a control

The intervention is implemented using the food distribution points providing supplementary food (CSB14, CSB+, RUSF, SC+) to children once they reach six months of age, and children from 6 to 23 months. This study will enroll all children as they turn six months of age and follow them through their 23rd month of age. Variables to be tracked include: age, sex, arm of study/commodity received ,Mid-Upper Arm Circumference (MUAC), height for age, weight for age, weight for height, month-to-month linear growth and weight gain, incidence of stunting (height for age below -2 Standard Deviations (SD)), incidence of wasting (weight for height below - 2 SD).

At 24 months, children stop receiving supplementary food. The study will continue to monitor these variables for at least an additional 6 months (through the age of 30 months).

The study will collect information on the following additional variables from Beneficiary Mothers/Caretakers, Health and Nutrition Promoters (HNPs), Community Health Agents (CHAs), store owners who sell products comparable to those distributed, and PVO staff members.

  • Mothers' knowledge, attitude, and practices with respect to compliance with instructions about the preparation and use of the supplementary food
  • Time and money costs to Beneficiary Mothers/Caretakers of participating in the feeding program
  • Household Characteristics
  • Environmental characteristics
  • Community characteristics
  • Perceived barriers and factors facilitating Title II program effectiveness
  • Logistics and cost of procuring, warehousing and distributing the food to the food distribution point

Data Collection Time Points Data collection will be ongoing. It is expected that in order to reach our sample size, the study will need to enroll children on a rolling basis when they turn 6 months old for one year. All children will receive a food ration for 18 months, until they turn 2 years old. During this time period, the study will collect growth measurements (height, weight, MUAC) on every enrolled child at monthly intervals.

Throughout the study, qualitative and quantitative data will also be collected from Beneficiary Mothers/Caretakers, Health and Nutrition Promoters (HNPs), Community Health Agents (CHAs), and PVO staff members as described above. We will conduct qualitative open ended interviews with PVO staff members in their professional capacities, to learn of any challenges or strengths in implementing the procurement and distribution of new commodities.

We will also randomly select a small subsample of Beneficiary Mothers/Caretakers for in-home observations. The purpose of these observations is to observe aspects of the family's preparation and consumption of the ration that they would be unlikely to be able to report during focus groups or individual interviews, because respondents may not be conscious of their actions. Examples include: giving tastes of the ration to children while it is being cooked; how quickly the ration is covered after feeding; whether children are able to take tastes of leftover rations. We would follow a commonly used model of asking families to have a guest observer stay with them for up to a week during waking hours. The observer would collect information on these aspects of preparation and consumption methods and on other observable behavior (e.g. how many times a day the ration is made, whether covered while cooking, after cooking, after serving).

We will collect a small (2 tablespoon) sample of prepared ration from all individually interviewed Beneficiary Mothers/Caretakers. This will be used for laboratory assessment of the proportion of FVO in the porridge to validate our estimates of the CSB : Oil ratio as reported by the mother.

The objective of this study is to highlight which food product best prevents stunting and MAM, in the most cost effective way, thereby ultimately affecting future effective and efficient policy in food aid programs.

Being tested
CSB14, RUSF1, SC+
Medical subject headings
Child Nutrition Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CSB14Dietary supplement

  • RUSF1Dietary supplement

  • SC+Dietary supplement

Study groups in NCT02071563
Study groupRoleWhat they receive
CSB14Active comparatorIsocaloric amount and cost-effectiveness of CSB14 (with whey protein concentrate and enhanced micronutrient profile), prepared with fortified vegetable oil (FVO).
Receives: Dietary Supplement: CSB14
RUSF1Active comparatorIsocaloric amount and cost-effectiveness of Ready-to Use Supplementary Food 1(RUSF1), USAID's Lipid-Based Nutrient Supplement (LNS) product
Receives: Dietary Supplement: RUSF1
SC+Active comparatorIsocaloric amount and cost-effectiveness of Supercereal Plus (SC+), the FBF used by WFP, which has an enhanced nutrient profile, dairy ingredient (non-fat dry milk), and oil already embedded into the flour
Receives: Dietary Supplement: SC+
CSB+No interventionIsocaloric amount and cost-effectiveness of Supercereal/CSB+ prepared with FVO.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of MAM and Stunting

    Primary outcomes to be measured are incidence of MAM and incidence of stunting during the 18 months of preventive supplementation (age 6 months to 23 months).

    Stunting will be defined as less than -2 SD of Height-for-Age Z-score and MAM will be defined as less than -2 SD Weight-for-Height (length) Z-score

    Measured: Monthly for 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Feb 2014 (estimated)
  2. Study startMar 2014
  3. Primary completionJan 2017
  4. Study completionJun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
6,039 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02071563
Sponsor's protocol ID
AID-016-Burkina Faso
Acronym
FAQR-Burkina
Status last verified
Oct 2017
First submitted
23 Sep 2013
Last updated
24 Oct 2017
Results posted
No
Data monitoring committee
Yes

Publications

  • Cliffer IR, Naumova EN, Masters WA, Perumal N, Garanet F, Rogers BL. Peak timing of slowest growth velocity among young children coincides with highest ambient temperatures in Burkina Faso: a longitudinal study. Am J Clin Nutr. 2024 Feb;119(2):393-405. doi: 10.1016/j.ajcnut.2023.09.021. Epub 2023 Dec 29.

    PubMed 38309828
  • Cliffer IR, Masters WA, Perumal N, Naumova EN, Zeba AN, Garanet F, Rogers BL. Monthly measurement of child lengths between 6 and 27 months of age in Burkina Faso reveals both chronic and episodic growth faltering. Am J Clin Nutr. 2022 Jan 11;115(1):94-104. doi: 10.1093/ajcn/nqab309.

    PubMed 34637506
  • Shen Y, Cliffer IR, Suri DJ, Langlois BK, Vosti SA, Webb P, Rogers BL. Impact of stakeholder perspectives on cost-effectiveness estimates of four specialized nutritious foods for preventing stunting and wasting in children 6-23 months in Burkina Faso. Nutr J. 2020 Feb 27;19(1):20. doi: 10.1186/s12937-020-00535-x.

    PubMed 32106840
  • Cliffer IR, Nikiema L, Langlois BK, Zeba AN, Shen Y, Lanou HB, Suri DJ, Garanet F, Chui K, Vosti S, Walton S, Rosenberg I, Webb P, Rogers BL. Cost-Effectiveness of 4 Specialized Nutritious Foods in the Prevention of Stunting and Wasting in Children Aged 6-23 Months in Burkina Faso: A Geographically Randomized Trial. Curr Dev Nutr. 2020 Jan 23;4(2):nzaa006. doi: 10.1093/cdn/nzaa006. eCollection 2020 Feb.

    PubMed 32072130
  • Langlois BK, Cliffer IR, Nikiema L, Suri DJ, Garanet F, Shen Y, Zeba AN, Walton SM, Lanou HB, Webb P, Rogers BL. Factors that May Influence the Effectiveness of 4 Specialized Nutritious Foods in the Prevention of Stunting and Wasting in Children Aged 6-23 Months in Burkina Faso. Curr Dev Nutr. 2020 Jan 6;4(2):nzaa002. doi: 10.1093/cdn/nzaa002. eCollection 2020 Feb.

    PubMed 31998858

Questions about this trial

What is this clinical trial studying?

A study testing CSB14, RUSF1 and SC+ in people with Child Malnutrition, run by Tufts University at 1 site in Burkina Faso.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 26 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Burkina Faso. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of MAM and Stunting (time frame: Monthly for 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02071563, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in